Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006–2019

Pär Karlsson(Karolinska Institutet), Carolyn E. Cesta(Karolinska Institutet), Marijo Otero‐Lobato(Janssen (Netherlands)), Karin Gembert(Karolinska Institutet), Mika Gissler(Finnish Institute for Health and Welfare), Anja Geldhof, Maarit K. Leinonen(University of Helsinki), Lars Pedersen(Aarhus University Hospital), Suzan Esslinger
Pharmacoepidemiology and Drug Safety
August 1, 2024
Cited by 3


Related Papers